Genesys International approves up to Rs 13,930 Lakh rights issue

What Genesys International announced

On 26 June 2026, the Board of Directors of Genesys International Corporation Limited (NSE: GENESYS) approved a rights issue of equity shares. The issue is capped at Rs 13,930 Lakhs (approximately Rs 1,393 crore) and will be offered to shareholders who are on the record date, which will be notified separately. The shares carry a face value of Rs 5 per share. The filing does not disclose the exact number of shares to be issued, the issue price, the entitlement ratio, or the record date – all of which will be determined by the Board or a duly constituted committee.

"The Board also approved the constitution of the Rights Issue Committee, for the purposes of issue, offer and allotment of Equity Shares, and other matters in connection with or incidental to the Rights Issue." – Board resolution, 26 June 2026.

The approval was made under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, and is subject to all required regulatory and statutory clearances.

Details of the rights issue

• Type of securities: Equity shares.
• Mode of issuance: Rights issue – a non‑public offering to existing shareholders.
• Maximum amount: Up to Rs 13,930 Lakhs.
• Face value per share: Rs 5.
• Regulatory framework: Companies Act, 2013 (as amended); SEBI ICDR Regulations, 2018; SEBI LODR Regulations, 2015.
• Board meeting: Commenced at 11:35 a.m. and concluded at 11:56 a.m. on 26 June 2026.

The filing states that specific terms – such as the issue price, rights entitlement ratio, record date, timing of the issue and payment terms – will be decided by the Board or the Rights Issue Committee. No further quantitative details were provided.

Rights Issue Committee

The Board resolved to form a Rights Issue Committee to manage the entire process, including:

1. Finalising the issue price and entitlement ratio.
2. Determining the record date and subscription timeline.
3. Overseeing the offer, allotment and payment mechanisms.
4. Ensuring compliance with all applicable statutes and SEBI regulations.

The composition of the committee was not disclosed in the filing.

Key facts at a glance

Why this matters for investors

The approval signals Genesys International’s intent to raise fresh capital from its existing shareholder base. A rights issue, when executed, typically results in dilution of existing shareholdings unless shareholders subscribe proportionally. However, because the issue is limited to current shareholders, it offers them the first right to maintain their ownership percentage. The actual impact on shareholders will depend on the final issue price and entitlement ratio, which are yet to be announced. Until those parameters are disclosed, investors cannot calculate the exact dilution effect or the cost of participation.

Regulatory approvals are mandatory. The filing notes that the proposal is subject to SEBI and other statutory clearances. Any delay or condition imposed by regulators could affect the timing of the issue.

Conclusion

Genesys International’s board has cleared a rights issue that could raise up to Rs 13,930 Lakhs, with the specifics of pricing, entitlement and timing to be finalised by a newly formed Rights Issue Committee. The proposal now moves to the regulatory approval stage, after which the company will announce the record date and subscription details. Investors should watch for subsequent disclosures that will outline the exact terms and allow them to decide on participation.